Molecular Mechanisms of Apoptosis Induction in Cancer Systems

Apoptosis, or programmed cell death, is a tightly regulated process that eliminates damaged or unwanted cells. In cancer systems, the balance between survival and death signals is often shifted to favour proliferation, making the reactivation of apoptotic pathways a prime therapeutic goal. Two principal routes converge on the activation of caspases: the intrinsic (mitochondrial) pathway, governed by Bcl-2 family proteins and mitochondrial outer membrane permeabilisation, and the extrinsic (death receptor) pathway, triggered by ligand-induced receptor oligomerisation. Mitochondrial dysfunction, characterised by loss of membrane potential and release of cytochrome c, couples with endoplasmic reticulum stress and reactive oxygen species (ROS) generation to amplify apoptotic signals. Concurrently, survival cascades such as NF-κB and STAT3 are aberrantly activated in many tumours, suppressing cell death. Understanding the molecular interplay among these pathways has guided the development of agents that restore apoptotic sensitivity by targeting Bcl-2 proteins, modulating ROS levels, inhibiting pro-survival kinases and promoting death receptor signalling. Such strategies hold promise for overcoming resistance, improving chemotherapeutic efficacy and achieving durable tumour control.

Research from Nature Portfolio

Recent studies have elucidated how modulation of redox balance and transcription factor activity can re-engage apoptosis in lung cancer cells. In one seminal work, an agent derived from a sesquiterpene lactone triggered oxidative stress that induced both endoplasmic reticulum and mitochondrial dysfunction. This stress led to the glutathionylation and inhibition of STAT3, preventing its nuclear translocation and transcriptional activity. When combined with a standard chemotherapeutic, the agent enhanced intracellular drug accumulation and sensitised resistant cells to apoptosis, illustrating a dual mechanism of redox-mediated death and chemosensitisation.

Molecular Mechanisms of Apoptosis Induction in Cancer Systems publication trend

The graph below shows the total number of articles in molecular mechanisms of apoptosis induction in cancer systems across all publications each year (not limited to Nature Index journals).

Technical terms

Apoptosis: programmed cell death involving caspase activation and orderly cellular disassembly.

Caspases: cysteine proteases that execute apoptosis by cleaving key substrates.

Bcl-2 family proteins: regulators of mitochondrial permeabilisation, comprising both pro-apoptotic (e.g. Bax) and anti-apoptotic (e.g. Bcl-2) members.

Reactive oxygen species (ROS): highly reactive molecules that can damage cellular components and trigger apoptotic pathways.

Mitochondrial membrane potential: electrochemical gradient essential for ATP synthesis; its loss leads to cytochrome c release.

Endoplasmic reticulum stress (ER stress): disturbance in ER protein folding that activates the unfolded protein response and can initiate apoptosis.

Signal transducer and activator of transcription 3 (STAT3): transcription factor that promotes cell survival and proliferation when activated.

Dynamin-related protein 1 (Drp1): GTPase controlling mitochondrial fission; its phosphorylation status influences apoptotic susceptibility.

Ectodomain shedding: proteolytic cleavage of a receptor’s extracellular domain, regulating signal transduction.

References

1. Alantolactone induces apoptosis, promotes STAT3 glutathionylation and enhances chemosensitivity of A549 lung adenocarcinoma cells to doxorubicin via oxidative stress. Scientific Reports (2017).
2. Mitochondrial impairment and downregulation of Drp1 phosphorylation underlie the antiproliferative and proapoptotic effects of alantolactone on oral squamous cell carcinoma cells. Journal of Translational Medicine (2023).
3. Sesquiterpene Lactones Containing an α-Methylene-γ-Lactone Moiety Selectively Down-Regulate the Expression of Tumor Necrosis Factor Receptor 1 by Promoting Its Ectodomain Shedding in Human Lung Adenocarcinoma A549 Cells. Molecules (2024).